Navigation Links
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
Date:11/14/2013

CRANBURY, N.J., Nov. 14, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced results for its first quarter ended September 30, 2013. 

Recent Highlights
Bremelanotide development for Female Sexual Dysfunction (FSD):

  • Successful completion of device bioequivalence trial
  • Receipt of a $1.0 million, non-refundable option fee relating to negotiation of a potential future license of bremelanotide in a defined territory outside North America
  • Pivotal Phase 3 clinical trials anticipated to start in the first quarter of calendar year 2014
  • The Company obtained patents during the quarter:

  • U.S. Patent 8,487,073, entitled "Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction" issued July 16, 2013, claiming composition of matter on novel peptides for treatment of sexual dysfunction, obesity and related indications
  • U.S. Patent No. 8,492,517, entitled "Melanocortin-1 Receptor-Specific Cyclic Peptides" issued July 23, 2013, claiming composition of matter of lead peptides for treatment of inflammation-related diseases
  • First Quarter Fiscal 2014 Financial Results
    Palatin reported a net loss of $4.5 million, or $(0.04) per basic and diluted share, for the quarter ended September 30, 2013, compared to a net loss of $10.5 million, or $(0.15) per basic and diluted share, for the same period in 2012.The decrease in net loss for the quarter ended September 30, 2013 compared to the same period last fiscal year was mainly attributable to the recognition of a $7.1 million, non-operating expense, in the quarter ended September 30, 2012, which represented the increase in fair value of warrants issued in connection with Palatin'
    '/>"/>

    SOURCE Palatin Technologies, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
    2. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
    3. Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
    4. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
    5. Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
    6. Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
    7. Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents
    8. Palatin Technologies Announces Option for License to Bremelanotide in Europe
    9. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
    10. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
    11. Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/6/2015)... July 6, 2015 Mauna ... the multidisciplinary confocal laser endomicroscopy platform, announced today ... Ministry of Health, Labor and Welfare ... solution, the AQ-Flex 19 miniprobe.   ... 19 miniprobe is comprised of a fiber-optic microscope ...
    (Date:7/6/2015)... , July 6, 2015  Protiviti, a global consulting ... Internal Auditing around the World publication ( www.protiviti.com/iaworld ... and reported on the evolution of the internal audit ... the globe as a means to providing senior executives ... this strategic business function. The 2015 edition ...
    (Date:7/6/2015)... June 29, 2015 Research ... the "Pharmaceutical Grade Sodium Chloride Market by Applications, ... report to their offering. The pharmaceutical ... CAGR of 6.9% between 2014 and 2019 in terms ... 690 KT by 2019. The report on ...
    Breaking Medicine Technology:Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
    ... N.J., May 16, 2011 New Jersey Center for ... in the nation to treat advanced prostate cancer patients ... class known as autologous cellular immunotherapies.  PROVENGE was approved ... the treatment of men with asymptomatic or minimally symptomatic ...
    ... public health, and regulatory highlights for this week from the ... designed for credentialed journalists. Release dates and times for items ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) FDA News & Notes ... legal limitations. Events and Speeches for ...
    Cached Medicine Technology:New Jersey Center for Prostate Cancer & Urology Among First in Nation to Treat Advanced Prostate Cancer Patients with PROVENGE 2FDA News & Notes - Week of May 16, 2011 2FDA News & Notes - Week of May 16, 2011 3
    (Date:7/6/2015)... ... July 06, 2015 , ... Invitation to Cover: , ... is a large gap between the unmet health priorities in the region and ... and reduce unnecessary or ineffective treatments or procedures. , This milestone conference, sponsored ...
    (Date:7/6/2015)... ... 06, 2015 , ... doTERRA, the leading global essential oils company, is pleased ... Jowers held the position as Director of the Hinckley Institute at the University of ... the institute, Jowers states that he was ready for a new challenge, and out ...
    (Date:7/6/2015)... ... July 06, 2015 , ... With a new community program ... up with Family Emergency Shelter Coalition (FESCO) and announced a new charity campaign ... especially to provide emergency services and support for homeless families, all the while ...
    (Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... World renowned ... the opportunity to achieve their ideal appearance through comprehensive treatment solutions. Individuals that want ... with the doctor and receive a plan that resolves each of their needs. ...
    (Date:7/6/2015)... ... , ... Thanks to donations and a generous grant from the GAR Foundation, ... for hospice patients and adult day center participants. , The Music & Memory program ... to their families and volunteers. Music & Memory is a non-profit organization that helps ...
    Breaking Medicine News(10 mins):Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4
    ... Colorectal cancer is a leading cause of cancer-related deaths ... every year. But it can be prevented with early ... from North Carolina State University, Mayo Clinic and the ... tool to help colonoscopy facilities operate more efficiently, ultimately ...
    ... of secondhand smoke have led some organizations and communities ... public venues. The effectiveness of such bans in ... tobacco smoke has been a matter of continuing debate. ... the Evidence, a new report from the Institute of ...
    ... Preventive Medicine (ACPM) supports the recommendations of the US ... should screen all adults for depression, and further recommends ... place to ensure the accurate diagnosis and treatment of ... identify depression are in the clinics of primary care ...
    ... ... press - the savings that can be made and the quality of the care. A ... , ... tourism has been around since the Romans. In recent years however, growing numbers of people are ...
    ... ... , ... October 6, 2009 -- KelseyCare Advantage , a Houston-based Medicare Advantage plan serving ... Galveston on the Mainland, recently reported its Healthcare Effectiveness Data and Information Set (HEDIS) ...
    ... use is likely to increase, experts say , TUESDAY, Oct. ... ADHD, depression and social phobia are more likely to be ... , Because computer use is a way of life in ... to become a major public health problem, the Taiwanese study ...
    Cached Medicine News:Health News:Study shows how to lower costs, waiting times for colonoscopies 2Health News:85% of People Would Consider Medical Tourism 2Health News:85% of People Would Consider Medical Tourism 3Health News:Local Medicare Advantage Plan Scores High on Diabetic Care and Blood Pressure Control 2Health News:Teens With ADHD, Depression Risk Internet Addiction 2Health News:Teens With ADHD, Depression Risk Internet Addiction 3
    ... to quality patient care., ,S/5 Anesthesia ... to anesthesia delivery. As part of the ... features, electronically controlled gas delivery and agent ... to create a truly integrated system. The ...
    ... Tegagel hydrogel wound filler and ... are amorphous hydrogel dressings specially formulated ... that has been shown to enhance ... formula meets clinical needs for management ...
    ... SS is a complete physician preference card ... management system for all the supply management ... preference card system combined with a broad ... entire case cart and operating suite supply ...
    Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
    Medicine Products: